X4 Pharmaceuticals adds CAMP4 Therapeutics CFO Kelly Gold to its board

X4 named Kelly Gold an independent director and Audit Committee member effective July 1, 2026, expanding its board to six seats.

X4 Pharmaceuticals (Nasdaq: XFOR) said on July 1, 2026 that it had appointed Kelly Gold to its board of directors, effective that day. The company described Gold as an experienced chief financial officer joining to add strategic and financial expertise.¹ Gold will serve as an independent director and a member of the Audit Committee.¹

According to the accompanying 8-K, X4's board appointed Gold as a Class II director effective July 1, 2026, and her addition increased the board's size from five to six directors.¹ She was also named to the Audit Committee.¹

Earlier, she was Associate Director, Strategic Corporate Finance at Biogen Inc. (Nasdaq: BIIB) from 2014 to 2017, working on financial planning for the company's late-stage and marketed rare disease programs.¹ From 2009 to 2013 she worked as a Healthcare Investment Banking Associate at Deutsche Bank.¹

The two company documents give differing accounts of Gold's undergraduate science degree.

Gold's board compensation will follow X4's non-employee director policy as described in its Definitive Proxy Statement filed March 20, 2026.¹ The filing states there are no arrangements between Gold and any other person related to her appointment and no family relationships with existing directors or officers.¹

Fact check notes

Checker's noteThe claim that 'X4 has not clarified which description is correct' is an editorial inference not supported by the source documents, which simply contain the discrepancy without any commentary on clarification.
Sentence removedGold has served as Chief Financial Officer of CAMP4 Therapeutics Corporation, a clinical-stage biopharmaceutical company (Nasdaq: CAMP), since April 2022.copied source wording
Sentence removedShe previously served as CAMP4's Chief Business Officer from April 2021 to March 2022 and held finance and corporate development roles at CAMP4 from 2017 to March 2021.copied source wording
Sentence removedThe 8-K states she earned bachelor's degrees in Life Sciences and Mechanical Engineering from Queen's University in Ontario and an MBA from the MIT Sloan School of Management, while the press release states she holds bachelor's degrees in Biochemistry and Mechanical Engineering from Queen's University in Ontario, as well as an MBA from the MIT Sloan School of Management.copied source wording
Sentence removedX4 has not clarified which description is correct.unsupported: Sources contain no statement about X4 clarifying or not clarifying the discrepancy; this is an inference not stated in either document.

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Where the check questioned a sentence, its note is shown above. Not investment advice.